Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/13/24 18:27 | 9/11/24 | CDTX | Health | BioPrd | Biological Products, (No Diag | Sandison Taylor | CA | O | Chief Me | 2 | S | -25 | 1.14 | 0 | -22 | 347 | D | |||||||||||||||
9/13/24 18:26 | 9/11/24 | CDTX | Health | BioPrd | Biological Products, (No Diag | Tari Leslie | CA | O | CHIEF SC | 2 | S | -25 | 1.12 | 0 | -22 | 260 | D | |||||||||||||||
3/12/24 21:46 | 3/11/24 | CDTX | Health | BioPrd | Biological Products, (No Diag | Ward Shane | CA | O | COO,CLO | 1 | S | -14 | 0.6698 | 0 | -20 | 199 | D | |||||||||||||||
3/12/24 21:45 | 3/11/24 | CDTX | Health | BioPrd | Biological Products, (No Diag | Shah Preetam | CA | O | CFO,CBO | 1 | S | -13 | 0.6698 | 0 | -19 | 227 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |